News

Take a look at our latest updates across different markets regarding launches, alliances, participations, events, expert opinions and more.

UY EC PE CL ARG
10.2024

Varifarma at CPHI 2024: Leading innovation.

 Leading the pharmaceutical industry into the future.

UY CL PE EC ARG
10.2024

At the forefront of oncohematology: Varifarma at the New York Congress

 24th Lymphoma, Leukemia, and Myeloma Congress: the ideal scenario to reaffirm our commitment.

UY
10.2024

Varifarma: shaping the future of Hematology in Uruguay

We had the pleasure of attending the Hematology Update Conference on October 1st.

EC CL PE UY ARG
10.2024

ESMO 2024: Oncology advances with Varifarma!

A record-breaking congress with the latest innovations.  

ARG
09.2024

BOCIPAL® (Relugolix 40mg) HAS BEEN LAUNCHED!

A different approach to managing symptoms associated with uterine fibroids.

ARG
09.2024

Gorax Symposium: A Full House! Discover the Highlights

Connecting with the medical community at the 61st Argentine Congress of Urology, hosted by the SAU.

UY
08.2024

Varifarma presented new launch, VARITRINOX (Arsenic Trioxide)

As part of the Interior Conferences organized by the Hematology Society.

ARG
08.2024

Innovation arrives in Mycosis Fungoide treatment with Ledaga® (Chlomethine gel)

We launched Ledaga®, the first gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma approved in Argentina.

ARG
08.2024

Gorax® (Relugolix 120mg) is now featured in NCCN and AAOC guidelines!

Both the medical community and Varifarma have reason to celebrate! Our product has been added to two of the leading medical recommendation guidelines.

UY
07.2024

¡Our new Uruguay website is live!

We're excited to unveil our new Uruguay website.

PE
07.2024

Varifarma in the XXIX Peruvian Congress of Neurology

Another year of expanding our scientific expertise in this academic event.

UY CL EC PE ARG
06.2024

Another year participating in the American Society of Clinical Oncology (ASCO) annual meeting!

In Varifarma we continue to take part in scientific events to stay at the forefront of new healthcare innovations.

UY ARG PE
06.2024

Introducing Endopredict, the prognostic test for Breast Cancer!

Find the latest news of this innovative test as a genomic tool to evaluate tumour behavior over the years for an accurate choice of treatment.

UY
05.2024

Varifarma at the Second Integrated Conference of the Academic Hematology Unit

Present at the “Daily Hematology” Conference in Montevideo from April 24 to 26.

UY PER
04.2024

myChoice CDx Plus, recognized with Level of Evidence 1A

Our genomic test myChoice CDx Plus has been recognized by the ESGO-ESMO-ESP 2024 consensus with a Level of Evidence 1A.

ARG
04.2024

Launch of GORAX® at the International Symposium of the SAU

Varifarma launched GORAX® (Relugolix) at the International Symposium “Advances in Urology 2024” organized by the Argentine Society of Urology.

ARG
03.2024

Innovation Arriving to Advanced Prostate Cancer Treatment

We Launched Gorax (Relugolix) 120mg, the first LHRH antagonist with oral intake in Argentina.
Developed by Varifarma, Gorax is a revolutionary breakthrough in advanced prostate cancer treatment.

ARG
02.2024

News in Haematology! We’re Launching Phelinum (Melphalan)

A new therapeutic alternative with multiple indications arrives to Varifarma!

ARG
02.2024

Our new presentation of Tepadina in Argentina!

We continue to increase our treatment options for our patients! We’re launching Tepadina 400mg.

ARG
12.2023

Our 2023 in Launches!

Another year full of innovation, launches, and new options for patients. We celebrate a year of innovation and progress at Varifarma 2023: Launches that make a difference!

UY
11.2023

Present at the XVII Congress of the SHU

Within the framework of the congress, the 1st meeting of the Uruguayan Lymphoma Group (GULI) and the XVII Hemato-Oncological Nursing Workshops were held.

PE
11.2023

Immunotherapy with Blinatumomab in ALL

Varifarma was present at the recent course of the Peruvian Society of Hematology on Immunotherapy with Blinatumomab to explore pioneering advances in the treatment of Acute Lymphoblastic Leukemia (ALL). Dr. Laura García from Mexico gave a presentation highlighting the fundamental role of this innovative therapy and the importance of accurate patient profiling.

UY
10.2023

Advances in Medical Education: SUEM Workshop on Pituitary Pathology

SUEM Workshop on Pituitary Pathology: Cushing and Acromegaly in Uruguay, with the presence of VARIFARMA and participation of distinguished experts.

CL ARG
09.2022

Free virtual course by SAH

We support the Argentine Society of Hematology in the continuous medical education of professionals.